Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome

Thrombosis Research

Volumn 80, Issue 6, 1995, Pages 519-526

  Gando, Satoshi ^a   Kameue, Takashi ^a   Nanzaki, Satoshi ^a   Nakanishi, Yoshimi ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

disseminated intravascular coagulation; interleukin 1 beta; soluble thrombomodulin; systemic inflammatory response syndrome; tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 1BETA; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; INFLAMMATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL;

ADULT; CYTOKINES; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS SYNDROME; THROMBOMODULIN; THROMBOSIS;

EID: 0028845992     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00207-3     Document Type: Article

References (18)

1. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome
3. Role of tumor necrosis factor-alpha in disease states and inflammation
4. Endothelial-leukocyte adhesion molecules in human disease
5. Adhesion molecules and inflammatory injury
6. The pathogenesis of sepsis
7. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
8. Thrombomodulin is present in human plasma and urine
9. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells
10. APACHE II
11. An expanded definition of the adult respiratory distress syndrome
12. Multiple organ failure. Pathophysiology and potential future therapy
13. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study
14. Consumptive thrombohemorrhagic disorders
15. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure
16. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
17. Changes in thrombomodulin level in plasma of endotoxin-induced disseminated intravascular coagulation and the effect of heparin
18. Plasma thrombomodulin in health and diseases